DaVita

Provides comprehensive kidney care services

Denver, Colorado, United States

About DaVita

DaVita provides specialized kidney care services for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company operates a network of dialysis centers where patients receive treatment, along with offering educational resources and dietary guidance to help manage their kidney health. DaVita's approach is centered around value-based care, which means they focus on improving patient outcomes while also aiming to reduce healthcare costs. They track treatment effectiveness using clinical metrics and provide proactive education through programs like Kidney Smart classes. What sets DaVita apart from its competitors is its commitment to holistic and equitable care, striving to transform the kidney care landscape and foster a supportive healthcare community.

Denver, ColoradoHeadquarters
1979Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Paid Vacation
Family Planning Benefits
Professional Development Budget
Mental Health Support
Pet Insurance

Risks

Emerging competition from biotechnology firms like eGenesis threatens DaVita's dialysis model.
Legal issues, such as the $34 million kickback settlement, pose reputational and financial risks.
Leadership changes may lead to strategic shifts impacting operations and employee morale.

Differentiation

DaVita focuses on value-based, patient-centric kidney care services.
The company offers integrated care programs to improve patient outcomes and reduce costs.
DaVita provides educational resources like Kidney Smart classes for proactive kidney health management.

Upsides

Telehealth expansion can enhance DaVita's patient access and chronic disease management.
Wearable health technology integration can improve real-time patient monitoring and outcomes.
AI utilization can personalize treatment plans and predict disease progression for better outcomes.

Funding

Total raised$750
StageIPO
POST IPO DEBT
1/31/2021
$750